Richard M. Stone, MD | Authors

Articles

Monitoring MRD in Patients with AML

October 30, 2017

Video

Richard M. Stone, MD, director of the Adult Leukemia Program, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses monitoring minimal residual disease (MRD) in patients with acute myeloid leukemia (AML).

The Genetic Landscape of AML

April 12, 2017

Video

Richard M. Stone, MD, discusses what is currently understood regarding the genetic landscape in acute myeloid leukemia (AML).